$Moderna(MRNA.US) +177% is validation that mRNA isn’t just for COVID. First Phase 3 cancer win with $Merck(MRK.US) opens a massive new market. And SK Hynix buying back means memory demand is real - $Sandisk(SNDK.US) and $Micron Tech(MU.US) catching that bid makes sense.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
